Early response to bleomycin is characterized by different cytokine and cytokine receptor profiles in lungs

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 287, Issue 6 31-6, 2004, Pages

  Cavarra, Eleonora ^a   Carraro, Fabio ^a   Fineschi, Silvia ^a   Naldini, Antonella ^a   Bartalesi, Barbara ^a   Pucci, Annalisa ^a   Lungarella, Giuseppe ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Cytokine and receptor profile; Early fibrogenic response; Mouse strains

Indexed keywords

BLEOMYCIN; CYTOKINE; CYTOKINE RECEPTOR; GLYCOPROTEIN GP 130; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; RIBONUCLEASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; LUNG; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RIBONUCLEASE PROTECTION ASSAY; UPREGULATION;

ANIMALS; BLEOMYCIN; CYTOKINES; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; LUNG; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTORS, CYTOKINE; RECEPTORS, INTERLEUKIN-1; RNA, MESSENGER;

EID: 8644269737     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00170.2004     Document Type: Article

References (47)

1. Adamson IYR and Bowden DH. The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Am J Pathol 77: 185-198, 1974.
2. Allen JT and Spiteri MA. Growth factors in idiopathic pulmonary fibrosis: relative roles. Respir Res 3: 13-21, 2002.
3. Aso Y and Ioneda Y. Morphological and biochemical study of pulmonary changes induced by bleomycin in mice. Lab Invest 35: 558-568, 1976.
4. Belperio JA, Dy M, Burdick MD, Xue YY, Li K, Elias JA, Keane MP. Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 27: 419-427, 2002.
5. Chen ES, Greenlee BM, Wills-Karp M, and Moller DR. Attenuation of lung inflammation and fibrosis in interferon-gamma-deficient mice after intratracheal bleomycin. Am J Respir Cell Mol Biol 24: 545-555, 2001.
6. Coker RK and Laurent GJ. Pulmonary fibrosis: cytokines in the balance. Eur Respir J 11: 1218-1221, 1998.
7. Crystal RG, Fulmer JD, Roberts WC, Moss ML, Line BR, and Reynolds HY. Idiopathic pulmonary fibrosis: clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. Ann Intern Med 85: 769-788, 1976.
8. Dinarello CA. Interleukin-1. Cytokine Growth Factor Rev 8: 253-265, 1997.
9. Eickelberg O, Pansky A, Mussmann R, Bihl M, Tamm M, Hildebrand P, Perruchoud AP, and Roth M. Transforming growth factor-beta1 induces interleukin-6 expression via activating protein-1 consisting of JunD homodimers in primary human lung fibroblasts. J Biol Chem 274: 12933-12938, 1999.
10. Elias JA, Freundlich B, Adams S, and Rosenbloom J. Regulation of human lung fibroblast collagen production by recombinant interleukin-1, tumor necrosis factor, and interferon-gamma. Ann NY Acad Sci 580: 233-244, 1990.
11. Gauldie J, Galt T, Anzano MA, Deng C, and Roberts AB. SMAD3 KO mouse is resistant to gene based TGF-beta1 induced fibrosis: lack of activation of CTGF (Abstract). Am J Respir Crit Care Med 164: A179, 2001.
12. Gur I, Or R, Segel MJ, Shriki M, Izbicki G, and Breuer R. Lymphokines in bleomycin-induced lung injury in bleomycin-sensitive C57BL/6 and -resistant BALB/c mice. Exp Lung Res 26: 521-534, 2000.
13. Hance A and Crystal RG. Idiopathic pulmonary fibrosis. In: Recent Advances in Respiratory Medicine, edited by Flenley DC and Petty TL. New York: Livingstone, 1983, p. 249-287.
14. Haston CK and Travis EL. Murine susceptibility to radiation-induced pulmonary fibrosis is influenced by a genetic factor implicated in susceptibility to bleomycin-induced pulmonary fibrosis. Cancer Res 57: 5286-5291, 1997.
15. Haston CK, Wang M, Dejournett RE, Zhou X, Ni D, Gu X, King TM, Weil MM, Newman RA, Amos CI, and Travis EL. Bleomycin hydrolase and a genetic locus within the MHC affect risk for pulmonary fibrosis in mice. Hum Mol Genet 11: 1855-1863, 2002.
16. Huaux F, Liu T, McGarry B, Ullenbruch M, and Phan SH. Dual roles of IL-4 in lung injury and fibrosis. J Immunol 170: 2083-2092, 2003.
17. Huaux F, Liu T, McGarry B, Ullenbruch M, Xing Z, and Phan SH. Eosinophils and T lymphocytes possess distinct roles in bleomycin-induced lung injury and fibrosis. J Immunol 171: 5470-5481, 2003.
18. Izbicki G and Breuer R. IL-4 is not a key profibrotic cytokine in bleomycin-induced lung fibrosis model. J Immunol 171: 2767-2768, 2003.
19. Izbicki G, Or R, Christensen TG, Segel MJ, Fine A, Goldstein RH, and Breuer R. Bleomycin-induced lung fibrosis in IL-4-overexpressing and knockout mice. Am J Physiol Lung Cell Mol Physiol 283: L1110-L1116, 2002.
20. Jakubzick C, Choi ES, Joshi BH, Keane MP, Kunkel SL, Puri RK, and Hogaboam CM. Therapeutic attenuation of pulmonary fibrosis via targeting of IL-4- and IL-13-responsive cells. J Immunol 171: 2684-2693, 2003.
21. Johnston CJ, Piedboeuf B, Rubin P, Williams JP, Baggs R, and Finkelstein JN. Early and persistent alterations in the expression of interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor alpha mRNA levels in fibrosis-resistant and sensitive mice after thoracic irradiation. Radiat Res 145: 762-767, 1996.
22. Keane MP and Strieter RM. The importance of balanced pro-inflammatory and anti-inflammatory mechanisms in diffuse lung disease. Respir Res 3: 5-11, 2002.
23. Knight DA, Ernst M, Anderson GP, Moodley YP, and Mutsaers SE. The role of gp130/IL-6 cytokines in the development of pulmonary fibrosis: critical determinants of disease susceptibility and progression? Pharmacol Ther 99: 327-338, 2003.
24. Kolb M, Margetts PJ, Anthony DC, Pitossi F, and Gauldie J. Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest 107: 1529-1536, 2001.
25. Lasky JA and Brody AR. Interstitial fibrosis and growth factors. Environ Health Perspect 108: 751-762, 2000.
26. Lasky JA, Ortiz LA, Tonthat B, Hoyle GW, Corti M, Athas G, Lungarella G, Brody A, and Friedman M. Connective tissue growth factor mRNA expression is upregulated in bleomycin-induced lung fibrosis. Am J Physiol Lung Cell Mol Physiol 275: L365-L367, 1998.
27. Lee CG, Homer RJ, Zhu Z, Lanone S, Wang X, Koteliansky V, Shipley JM, Gotwals P, Noble P, Chen Q, Senior RM, and Elias JA. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta 1. J Exp Med 194: 809-822, 2001.
28. Losses IS, Or R, Ginzburg V, Christensen TG, Mashriki Y, and Breuer R. Cyclosporin A upmodulates bleomycin-induced pulmonary fibrosis in BALB/c mice. Respiration 69: 344-349, 2002.
29. Naldini A, Carney DH, Pucci A, and Carraro F. Human alpha-thrombin stimulates proliferation of interferon-gamma differentiated, growth-arrested U937 cells, overcoming differentiation-related changes in expression of p21CIP1/WAF1 and cyclin D1. J Cell Physiol 191: 290-297, 2002.
30. Oriente A, Fedarko NS, Pacocha SE, Huang SK, Lichtenstein LM, and Essayan DM. Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts. J Pharmacol Exp Ther 292: 988-994, 2000.
31. Ortiz LA, Lasky J, Gozal E, Ruiz V, Lungarella G, Cavarra E, Brody AR, Friedman M, Pardo A, and Selman M. Tumor necrosis factor receptor deficiency alters matrix metalloproteinase 13/tissue inhibitor of metalloproteinase 1 expression in murine silicosis. Am J Respir Crit Care Med 163: 244-252, 2001.
32. Ortiz LA, Lasky J, Hamilton RF, Holian A, Hoyle GW, Banks W, Peschon JJ, Brody AR, Lungarella G, and Friedman M. Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice. Exp Lung Res 24: 721-743, 1998.
33. Ortiz LA, Lasky J, Lungarella G, Cavarra E, Martorana P, Banks WA, Peschon JJ, Schmidts HL, Brody AR, and Friedman M. Upregulation of the p75 but not the p55 TNF-alpha receptor mRNA after silica and bleomycin exposure and protection from lung injury in double receptor knockout mice. Am J Respir Cell Mol Biol 20: 825-833, 1999.
34. Pan LH, Ohtani H, Yamauchi K, and Nagura H. Co-expression of TNF alpha and IL-1 beta in human acute pulmonary fibrotic diseases: an immunohistochemical analysis. Pathol Int 46: 91-99, 1996.
35. Phan SH and Kunkel SL. Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp Lung Res 18: 29-43, 1992.
36. Piguet PF, Collart MA, Grau GE, Kapanci Y, and Vassalli P. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J Exp Med 170: 655-663, 1989.
37. Piguet PF and Vesin C. Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. Eur Respir J 7: 515-518, 1994.
38. Piguet PF, Vesin C, Grau GE, and Thompson RC. Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica. Cytokine 5: 57-61, 1993.
39. Postlethwaite AE, Holness MA, Katai H, and Raghow R. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin-4. J Clin Invest 90: 1479-1485, 1992.
40. Romagnani S. Th1/Th2 cells. Inflamm Bowel Dis 5: 285-294, 1999.
41. Rudders RA and Hensley GT. Bleomycin pulmonary toxicity. Chest 63: 627-628, 1973.
42. Schrier DJ, Kunkel RG, and Phan SH. The role of strain variation in murine bleomycin-induced pulmonary fibrosis. Am Rev Respir Dis 127: 63-66, 1983.
43. Selman M, King TE, and Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 134: 136-151, 2001.
44. Sime PJ, Marr RA, Gauldie D, Xing Z, Hewlett BR, Graham FL, and Gauldie J. Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta 1 and myofibroblasts. Am J Pathol 153: 825-832, 1998.
45. Snider GL, Hayes JA, and Korthy AL. Chronic interstitial pulmonary fibrosis produced in hamsters by intratracheal bleomycin. Pathology and stereology. Am Rev Respir Dis 117: 1099-1108, 1978.
46. Wolff G and Crystal RG. Biology of pulmonary fibrosis. In: The Lung. Scientific Foundations, edited by Crystal RG, West JB, Weibel ER, and Barnes PJ. Philadelphia, PA: Lippincott-Raven, 1997, p. 2509-2524.
47. Zhang Y, Lee TC, Guillemin B, Yu MC, and Rom WN. Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J Immunol 150: 4188-4196, 1993.